NMPA Approval

Bortezomib for Injection

Approval Number

国药准字H20243569

Company健进制药有限公司

Registration Date

April 24, 2024

Drug Information

Generic Name

注射用硼替佐米

Dosage Form

注射剂

Strength

3.5mg

Drug Type

化学药品

Registration Date

April 24, 2024

Company Information

Applicant Company

Company Name健进制药有限公司

Company Address

四川省成都高新区西部园区科新路8号附9号

Manufacturing Company

Company Name健进制药有限公司

Company Address

成都高新综合保税区科新路8号附9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用硼替佐米 - NMPA 批准文号 | MedPath